Research

From circuits to compounds.

Team Woojin studies three linked problems: neuropathic pain circuits, oligodendrocytes and myelin, and the anorexia, cachexia, and metabolic effects of illness and chemotherapy. Plant-derived compounds are tested in the same models.

Focus

What the lab is trying to explain.

Pathological pain is not only a peripheral event. Inhibitory interneurons and the way somatosensory circuits handle incoming signals can fail, and those failures show up in behavior. Team Woojin studies that failure at two scales: the circuit and the cell.

Oligodendrocytes, oligodendrocyte precursor cells, and myelin are part of the same problem. The group treats them as active participants in pain, not as background insulation, and asks when their function drifts in neuropathy.

The therapeutic arm of the lab tests plant-derived compounds in the same models, looking for molecules that restore circuit function rather than only masking symptoms.

Programs at a glance

ProgramQuestionMain approaches
Pain circuits and glia How inhibitory interneurons, oligodendrocyte precursor cells, and myelin change somatosensory processing. Patch clamp, spinal and brain physiology, behavior
Chemotherapy neuropathy How paclitaxel and oxaliplatin alter pain circuits, and which plant-derived compounds reverse that change. Drug models, natural-product pharmacology
Anorexia and metabolism How cisplatin and diet-related signals affect appetite, muscle, and obesity pathways. Behavioral models, monoamine pharmacology, chromatography
01 — Circuits

Neuropathic pain

Somatosensory processing, inhibitory interneurons, and the cellular changes that lock in chronic pain.

  • Spinal and brain circuit physiology
  • Neuron–glia interactions
  • Behavioral readouts of pain states
02 — Glia

Oligodendrocytes and myelin

How OPCs, oligodendrocytes, and myelin contribute to pain, a direction developed with collaborators including Prof. María Cecilia Angulo.

  • Oligodendrocyte precursor cells
  • Myelin and circuit timing
  • Spinal LPA3 signaling
03 — Therapy

Natural products and systemic illness

Chemotherapy neuropathy, anorexia, cachexia, and metabolic disease, using medicinal compounds as both tools and candidate treatments.

  • Paclitaxel and oxaliplatin models
  • Anorexia and muscle wasting
  • Depression and obesity pathways

How the work is done

Multimodal patch clamp

Precise recordings of neuron and glia physiology, used to connect membrane events with circuit change.

Disease models

Neuropathic pain induced by neurosurgical injury or by chemotherapeutic drugs, read out in behavior.

Natural-product pharmacology

Extracts and defined metabolites, including work that uses chromatography to follow active constituents.

Monoamine systems

Noradrenergic and serotonergic contributions to analgesia, including electroacupuncture studies from the group.

Network pharmacology

Used alongside experiment to map how multi-component medicines may act on pain and metabolic targets.

Glial histology

Markers of astrocytes, microglia, and oligodendrocyte lineage cells in spinal and brain tissue.

Keywords

Neuropathic pain Oligodendrocytes OPC Myelin Anorexia Cachexia Depression Obesity Patch clamp Plant-derived compounds